Loading clinical trials...

Empower Korean Families to End Tobacco Use & Smoking Exposure | Clinical Trials | Clareo Health

COMPLETEDNA

Empower Korean Families to End Tobacco Use & Smoking Exposure

NCT04079569•University of California, San Francisco

Summary

The goals of the study are to develop a culturally and linguistically appropriate intervention to promote smoking cessation and reduce secondhand smoke exposure for Korean Americans using a family-based intervention approach targeting Korean Americans ages 18 and above in the greater San Francisco Bay Area, CA, and to evaluate efficacy of the proposed intervention. The study is a randomized control trial targeting a total of 8 lay health workers (LHW) and 48 dyads of a daily smoker and a partner who will attend intervention sessions together. The research question is: Can a family-based lay health worker outreach intervention promote smoking cessation and reduce SHS exposure among Korean Americans?

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•reside in California, United States
•for the smoker participants, they must have smoked at least 1 cigarette in the past 30 days, and have smoked either at least 1 cigarette and/or used e-cigarettes in the past 7 days, and self-identified as Korean or Korean American
•for partner participants, they must be willing to attend intervention session together with a smoker participant
•provide a valid contact telephone number and email address for pre- and post-intervention assessments

Locations (1)

Korean Community Center of the East Bay

San Leandro, California, United States

Key Dates

Start Date

August 19, 2019

Primary Completion Date

December 20, 2020

Completion Date

March 31, 2021

Last Updated

April 8, 2021

Enrollment

112

ACTUAL participants

Conditions

Smoking CessationLifestyle Risk Reduction

Interventions

Tobacco

BEHAVIORAL

Healthy Living

BEHAVIORAL

Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients

NCT07441928

Smoking CessationSchizophenia Disorder

View study

RECRUITINGPHASE2

Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study

NCT05733767

Cardiopulmonary DiseaseSmoking Cessation+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 8, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Empower Korean Families to End Tobacco Use & Smoking Exposure

Inclusion Criteria

Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients

Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study

Effects of Smoking Addiction on Lower Limb Speed and Coordination

tDCS Plus Varenicline for Smoking Cessation

Healing Within: Mindfulness Smoking Cessation Intervention

Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos